Guo‐Chao Zhong

机构：Dalian Medical University, Second Affiliated Hospital of Chongqing Medical University, Chongqing Medical University · ORCID：0000-0002-0280-7938

发表论文 72 篇 · 总被引 2100 次 · h-index 24

代表论文

• Integrative analysis reveals that SLC38A1 promotes hepatocellular carcinoma development via PI3K/AKT/mTOR signaling via glutamine mediated energy metabolism (2023 · Journal of Cancer Research and Clinical Oncology · 被引 31)
• Targeting FDFT1 Reduces Cholesterol and Bile Acid Production and Delays Hepatocellular Carcinoma Progression Through the HNF4A/ALDOB/AKT1 Axis (2025 · Advanced Science · 被引 22)
• Prediagnosis ultra-processed food consumption and prognosis of patients with colorectal, lung, prostate, or breast cancer: a large prospective multicenter study (2023 · Frontiers in Nutrition · 被引 15)
• Inhibiting cholesterol de novo synthesis promotes hepatocellular carcinoma progression by upregulating prostaglandin E synthase 2‐mediated arachidonic acid metabolism under high fatty acid conditions (2023 · Cancer Science · 被引 13)
• m6A demethylation of FOSL1 mRNA protects hepatoma cells against necrosis under glucose deprivation (2024 · Cell Death and Differentiation · 被引 7)
• Profiles of HBcrAg and pgRNA in Pregnant Women With Chronic HBV Under Different Disease Phases and Antiviral Prophylaxis (2024 · Open Forum Infectious Diseases · 被引 4)